申请人:QIAN Dapeng
公开号:US20110212053A1
公开(公告)日:2011-09-01
Provided are compounds according to Formula (I):
or stereoisomer, prodrug, polymorph, or pharmaceutically acceptable salt forms thereof, wherein X, Y, R
1
, R
6
, R
7
, and R
8
are as defined, and which compounds are effective inhibitors of PI3-kinase and/or other medically and clinically relevant kinases. Also provided are pharmaceutical compositions and methods of using the compounds and compositions as PI3-kinase and kinase inhibitors. More particularly, the compounds of the invention provide treatments and therapeutics for human diseases regulated by, or associated with, the activity of, PI3-kinases and/or protein kinases, or mutant or variant forms thereof.
提供了以下式子(I)的化合物,或其立体异构体、前药、多晶形或药学上可接受的盐形式,其中X、Y、R1、R6、R7和R8如定义所述,这些化合物是有效的PI3-激酶和/或其他医学和临床相关的激酶抑制剂。还提供了制备这些化合物和组合物作为PI3-激酶和激酶抑制剂的制药组合物和使用方法。更具体地,本发明的化合物为通过PI3-激酶和/或蛋白激酶活性调节或相关联的人类疾病,或其突变或变异形式提供治疗和治疗方法。